Literature DB >> 17653139

Endothelium-mediated modulation of ergoreflex and improvement in exercise ventilation by acute sildenafil in heart failure patients.

M Guazzi1, M Casali, F Berti, G Rossoni, V D'Gennaro Colonna, M D Guazzi.   

Abstract

Reflex neural oversignaling sensitive to muscle by-products (ergoreflex) causes exercise hyperventilation in heart failure (HF). We probed whether an improved endothelial function with sildenafil intake may prevent this effect. In 16 chronic heart failure patients and 16 normal subjects, before and after sildenafil intake (50 mg) or placebo, we measured ergoreflex, flow-mediated brachial artery dilation (FMD, an index of endothelial function), and, during maximal exercise, the slope of ventilation to carbon dioxide production (VE/VCO2, an index of ventilatory efficiency), the ratio of changes in O2 uptake (VO2) versus work rate (WR) (deltaVO2/deltaWR, an index of aerobic efficiency). After sildenafil intake, patients, unlike controls, showed a significant decrease in ergoreflex and VE/VCO2 slope and an increase in FMD and deltaVO2/deltaWR. Ergoreflex changes with sildenafil intake correlated with those in FMD and VE/VCO2. Phosphodiesterase-5 inhibition, by improving endothelial activity and muscle perfusion, modulates signaling and improves ventilatory and aerobic efficiencies, potentially indicating a novel pathway in the HF therapeutic management.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653139     DOI: 10.1038/sj.clpt.6100306

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  13 in total

1.  Endothelium-dependent vasodilation is associated with exercise capacity in smokers and non-smokers.

Authors:  Kevin S Heffernan; Richard H Karas; Eshan A Patvardhan; Jeffrey T Kuvin
Journal:  Vasc Med       Date:  2010-04       Impact factor: 3.239

Review 2.  Pulmonary vasodilation in acute and chronic heart failure: empiricism and evidence.

Authors:  Maya Guglin
Journal:  Curr Heart Fail Rep       Date:  2011-09

3.  Kinetics of skeletal muscle O2 delivery and utilization at the onset of heavy-intensity exercise in pulmonary arterial hypertension.

Authors:  Priscila B Barbosa; Eloara M V Ferreira; Jaquelina S O Arakaki; Luciana S Takara; Juliana Moura; Rúbia B Nascimento; Luiz E Nery; J Alberto Neder
Journal:  Eur J Appl Physiol       Date:  2011-01-12       Impact factor: 3.078

4.  Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept.

Authors:  Jonathan Rhodes; Ana Ubeda-Tikkanen; Mathieu Clair; Susan M Fernandes; Dionne A Graham; Carly E Milliren; Kevin P Daly; Mary P Mullen; Michael J Landzberg
Journal:  Int J Cardiol       Date:  2013-03-29       Impact factor: 4.164

5.  Comparative effectiveness of sildenafil for pulmonary hypertension due to left heart disease with HFrEF.

Authors:  Rong Jiang; Lan Wang; Chang-Tai Zhu; Ping Yuan; Bigyan Pudasaini; Qin-Hua Zhao; Su-Gang Gong; Jing He; Jin-Ming Liu; Qing-Hua Hu
Journal:  Hypertens Res       Date:  2015-07-23       Impact factor: 3.872

Review 6.  Sildenafil and phosphodiesterase-5 inhibitors for heart failure.

Authors:  Marco Guazzi
Journal:  Curr Heart Fail Rep       Date:  2008-06

Review 7.  Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research.

Authors:  Andreas P Kalogeropoulos; Vasiliki V Georgiopoulou; Barry A Borlaug; Mihai Gheorghiade; Javed Butler
Journal:  Circ Heart Fail       Date:  2013-05       Impact factor: 8.790

8.  Sildenafil in heart failure with reactive pulmonary hypertension (Sildenafil HF) clinical trial (rationale and design).

Authors:  Maya Guglin; Navin Rajagopalan; Paul Anaya; Richard Charnigo
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

9.  Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone.

Authors:  Gregory D Lewis; Ravi V Shah; Paul P Pappagianopolas; David M Systrom; Marc J Semigran
Journal:  Circ Heart Fail       Date:  2008-11       Impact factor: 8.790

Review 10.  Flow-mediated dilation and heart failure: a review with implications to physical rehabilitation.

Authors:  G P T Areas; A Mazzuco; F R Caruso; R B Jaenisch; R Cabiddu; S A Phillips; R Arena; A Borghi-Silva
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.